Severe covid-19
Key Clinical Points Evaluation and Management of Severe Covid-19 Patients with severe
coronavirus disease 2019 (Covid-19) may become critically ill with acute respiratory distress …
coronavirus disease 2019 (Covid-19) may become critically ill with acute respiratory distress …
Mild or moderate Covid-19
Key Clinical Points Mild or Moderate Covid-19 Covid-19 has a range of clinical
manifestations, including cough, fever, myalgias, gastrointestinal symptoms, and anosmia …
manifestations, including cough, fever, myalgias, gastrointestinal symptoms, and anosmia …
[HTML][HTML] Medical management of COVID-19: evidence and experience
Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …
Clinical outcomes of using remdesivir in patients with moderate to severe COVID-19: a prospective randomised study
L Mahajan, AP Singh - Indian journal of anaesthesia, 2021 - journals.lww.com
Methods: Participants more than 40-years old and with moderate to severe COVID-19 but
not on mechanical ventilation were randomly assigned into two groups-remdesivir group (34 …
not on mechanical ventilation were randomly assigned into two groups-remdesivir group (34 …
Intensive care management of patients with COVID-19: a practical approach
Abstract SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), is
responsible for the largest pandemic facing humanity since the Spanish flu pandemic in the …
responsible for the largest pandemic facing humanity since the Spanish flu pandemic in the …
Predictors of mortality in patients with severe COVID-19 pneumonia—a retrospective study
A Nuchin, R Kumar, PA Mahesh - Advances in respiratory medicine, 2021 - mdpi.com
Introduction: The novel coronavirus pandemic has caused significant mortality throughout
the world. This study was done as there is scarce data on mortality predictors in severe …
the world. This study was done as there is scarce data on mortality predictors in severe …
Novel coronavirus 2019 (COVID-19): a case report and review of treatments
S Douedi, J Miskoff - Medicine, 2020 - journals.lww.com
Interventions: She was being treated aggressively in the intensive care unit with high dose
intravenous ascorbic acid, hydroxychloroquine, and anti-interleukin-6 monoclonal antibody …
intravenous ascorbic acid, hydroxychloroquine, and anti-interleukin-6 monoclonal antibody …
[HTML][HTML] COVID-19: An overview and a clinical update
A Krishnan, JP Hamilton, SA Alqahtani… - World journal of clinical …, 2021 - ncbi.nlm.nih.gov
The outbreak of coronavirus disease-2019 (COVID-19, previously known as 2019 nCoV)
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in …
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in …
Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review
Importance The coronavirus disease 2019 (COVID-19) pandemic, due to the novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a worldwide sudden …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a worldwide sudden …
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post …
S Antinori, MV Cossu, AL Ridolfo, R Rech… - Pharmacological …, 2020 - Elsevier
SARS-CoV-2 is causing an increasing number of deaths worldwide because no effective
treatment is currently available. Remdesivir has shown in vitro activity against coronaviruses …
treatment is currently available. Remdesivir has shown in vitro activity against coronaviruses …